Skip to main content
. 2023 Jul 18;7:72. doi: 10.1186/s41687-023-00611-w

Table 1.

Core outcome set and corresponding PRO-CTCAE items

MedDRA system organ classes1 Core outcome sets2,3 Corresponding PRO-CTCAE items4
Gastrointestinal disorders
Constipation2 Constipation
Diarrhea2 Diarrhea
Nausea2 Nausea
Bloating3 Bloating
Vomiting3 Vomiting
Cramping3 Bloating/abdominal pain
Indigestion3 Diarrhea, constipation, abdominal pain
General disorders and administration site conditions
Pain2 Abdominal pain
Abdominal pain3 Abdominal pain
Fatigue2 Fatigue
Metabolism and nutrition disorders
Anorexia (appetite loss)2 Decreased appetite
Weight gain3 N/A
Weight loss3 Decreased appetite
Nervous system disorders
Sensory neuropathy2 Numbness & tingling
Psychiatric disorders
Anxiety (includes worry)2 Anxious
Cognitive problems2 Concentration, memory
Depression (includes sadness)2 Discouraged, sad
Fear of recurrence/disease progression3 N/A
Insomnia2 Insomnia
Reproductive system and breast disorders
Sexual dysfunction3 Decreased libido
Vaginal dryness
Respiratory, thoracic, and mediastinal disorders
Dyspnea2 Shortness of breath
Unique symptoms in total 21 18

MedDRA Medical Dictionary for Regulatory Activities, PRO-CTCAE Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events

1Medical Dictionary for Regulatory Activities (MEDDRA) [Internet]. Available from: https://www.meddra.org/ [39], 2Reeve et al. [41], 3Donovan et al. [42],4PRO-CTCAE. PRO-CTCAE® Measurement System website [Internet]. Available from: https://healthcaredelivery.cancer.gov/pro-ctcae [17]